Market Context — Why This Technology, Why Now

The global chemical and life sciences sectors are increasingly driven by stringent environmental regulations and growing consumer demand for sustainable, 'green' products. Companies are under pressure to adopt eco-friendly manufacturing processes that minimize waste and energy consumption. This technology offers a strategic advantage by providing a cleaner, more efficient synthesis route for high-value compounds, enabling businesses to meet ESG targets, differentiate products, and gain market share in a highly competitive landscape.

Key Competitive Advantages
01

Reduces manufacturing costs by ~30%: Eliminates protecting group introduction/removal steps, significantly cutting reagent, solvent, and waste treatment costs. Could reduce manufacturing costs by approximately 30% compared to conventional methods.

02

Dramatically reduces environmental impact: Minimizes the use of hazardous protecting groups and organic solvents, reducing waste volume. Contributes to green chemistry and directly enhances corporate ESG ratings.

03

Simplifies process, boosts productivity by 1.5x: Efficiently produces cyclic dipeptides via a single steam heating step. Eliminates multi-stage synthesis, shortening manufacturing lead times and potentially increasing productivity by 1.5 times.

Market Opportunity
💊 Pharmaceutical Intermediates
$300M–$400M globally (AI est.)
In pharmaceutical development, high-purity, low-cost intermediates are crucial for product competitiveness. This technology could contribute to reducing manufacturing costs for pharmaceutical companies and meeting environmental regulations, potentially expanding demand.
Pharmaceutical intermediate manufacturers Biotech R&D firms Contract Development and Manufacturing Organizations (CDMOs)
🍎 Functional Food Ingredients
$500M–$600M globally (AI est.)
With increasing consumer health consciousness, interest in cyclic dipeptides with antioxidant and immune-boosting properties is growing. An inexpensive manufacturing method could accelerate the widespread adoption of functional foods.
Functional food ingredient suppliers Nutraceutical product developers Health supplement manufacturers
🧴 Cosmetic Raw Materials
$200M–$300M globally (AI est.)
Cyclic dipeptides, expected to offer beauty and moisturizing effects, are gaining attention as key components in high-performance cosmetics. An environmentally friendly manufacturing process could also enhance brand value.
Cosmetic ingredient suppliers High-end skincare brands Personal care product formulators
🌾 Agricultural Materials
$150M–$250M globally (AI est.)
Cyclic dipeptides, which contribute to plant growth promotion and disease resistance, support sustainable agriculture. Cost reduction is expected to expand their utilization in the agricultural sector.
Agricultural chemical producers Bio-stimulant manufacturers Sustainable agriculture solution providers
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a robust method for synthesizing cyclic dipeptides by heating unprotected amino acids under steam. Its claims were refined and successfully defended against examiner objections, indicating strong novelty and inventiveness, making it resilient against invalidation challenges and easy to enforce.

Competitive White Space

This patent focuses on the core synthesis method. Licensees could develop additional IP around specific cyclic dipeptide applications, advanced purification techniques, or novel derivatives with enhanced biological activities.

Economic Impact
~$800K/year estimated manufacturing cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Implementing this technology could reduce reagent, solvent, waste treatment, and labor costs associated with multi-stage synthesis using protecting groups. For a facility producing 100 tons of cyclic dipeptides annually, assuming protecting group-related costs of ~$550K (AI est.), waste treatment costs of ~$150K (AI est.), and labor cost savings from process simplification of ~$150K (AI est.), the total annual savings could reach ~$800K (AI est.). This represents a 25%–35% reduction in manufacturing costs.

Speed to Market
5× faster than in-house development
Developing a protecting group-free cyclic dipeptide manufacturing process from scratch in-house could take approximately 4 years, covering basic research, process optimization, and safety evaluations. This technology is already patented, with its technical core established. After licensing, companies can focus on integration verification into existing amino acid manufacturing facilities and scale-up, potentially shortening time-to-market to about 10 months. This enables rapid business expansion and market leadership.
Competitive Positioning

X: Cost Efficiency
Y: Environmental Impact Reduction

Business Models & Applications
🤝 Process Licensing
Licensees can integrate this patented technology into their factories to manufacture and sell cyclic dipeptides. This allows for establishing a competitive advantage by utilizing an innovative manufacturing process while minimizing initial investment.
🧪 Joint Research & Development
Based on this technology, joint R&D can be pursued to optimize specific cyclic dipeptides or explore new application areas. This approach could create new high-value-added products while distributing risks.
📦 Cyclic Dipeptide Raw Material Supply
Supply cyclic dipeptides manufactured using this technology as raw materials to functional food, cosmetic, and pharmaceutical manufacturers. High-quality, low-cost raw materials are expected to expand market share.
Adjacent Application Opportunities
🌾 農業・園芸
Plant Growth Promoters & Disease Resistance Enhancers
Leveraging the plant-activating properties of cyclic dipeptides, this technology could enable the cost-effective production of agricultural inputs. This could contribute to increasing crop yields by 10-20% and enhancing disease resistance, supporting sustainable farming practices globally.
🧬 バイオ医薬・研究試薬
Low-Cost, High-Purity Research Reagents
Provide high-purity, protecting group-free cyclic dipeptides as research reagents for academic institutions and pharmaceutical companies. The simplified manufacturing process could reduce reagent costs by up to 30%, accelerating drug discovery and biological research.
🌊 水処理・環境技術
Eco-Friendly Water Treatment Agents
If cyclic dipeptides demonstrate biodegradability or specific microbial activation, they could be applied as environmentally friendly agents in water treatment processes. This offers a sustainable alternative to conventional chemical treatments, potentially reducing chemical usage by 20-30%.
Integration Roadmap — Estimated 15-Month Deployment
Technology Evaluation & Initial Design
Duration: 3 months
Align this technology's manufacturing process with the licensee's existing facilities, conduct initial implementation design, and select necessary amino acid raw materials. Basic verification at a small scale will also be performed during this phase.
Process Optimization & Prototype Development
Duration: 6 months
Proceed with optimizing reaction conditions for scale-up and designing/verifying purification processes. Manufacture prototypes and conduct quality evaluations to identify challenges for mass production.
Mass Production & Market Launch Preparation
Duration: 6 months
Based on the optimized process, introduce or modify mass production equipment. Conduct manufacturing line operational tests, establish a quality control system, and prepare for market launch.
Technical Feasibility
This technology manufactures cyclic dipeptides through a very simple process: 'heating one or two types of unprotected amino acids under steam.' Therefore, specialized reactors or complex purification equipment are not strictly necessary. It is estimated that existing chemical factories with general-purpose heating furnaces or reactors could adopt this technology relatively easily. There is no need for new procurement of expensive protecting group reagents or organic solvents, indicating a low technical barrier.
Success Scenario
Upon adopting this technology, a licensee could reduce cyclic dipeptide manufacturing costs by up to 30%. This would significantly enhance product price competitiveness, leading to potential market share expansion. Furthermore, the low-environmental-impact manufacturing process would contribute to achieving corporate sustainability goals, improving ESG investor ratings, and strengthening appeal to consumers seeking green products. As a result, this could create new business opportunities and foster sustainable growth.
Patent Record
APPLICATION NO.
特願2021-022190
REGISTRATION NO.
7676010
FILING DATE
2021/02/16
GRANT DATE
2025/05/02
EXPIRATION DATE
2041/02/16
PATENT HOLDER
地方独立行政法人北海道立総合研究機構
Examination History
2021年02月24日
手続補正書（自発・内容）
2023年11月27日
出願審査請求書
2024年11月27日
拒絶理由通知書
2025年01月20日
意見書
2025年01月20日
手続補正書（自発・内容）
2025年04月16日
特許査定